FDA Brief

Company record

Accriva Diagnostics, Inc.

0 FDA warning letters since 2023 and 4 recalls in the last 12 months.

Get an email the day FDA posts anything new about Accriva Diagnostics, Inc..

Recalls

ReportedClassFirmProduct and reason
Nov 11 Class II Accriva Diagnostics, Inc.
Device
Hemochron Jr., Whole Blood Microcoagulation System, Activated Partial Thromboplastin Time (APTT) Test Cuvette, REF: J103
Microcoagulation test used to evaluate low dose heparin anticoagulation has a mispositioned or absent clot activating reagent, which may result in out-of-range high error code, or erroneously high results, which may lead retest, or overestimation of patient's anticoagulation, leading to inadequate anticoagulant therapy, which could result in thrombosis.
Jun 24 Class II Accriva Diagnostics, Inc.
Device
directCHECK ACT-LR whole blood quality control, level 2 Model/Catalog Number: DCGLR-2
Assayed Whole blood control contains labeling with incorrect performance range.
Dec 10, 2025 Class II Accriva Diagnostics, Inc.
Device
Hemochron Activated Clotting Time Low-Range Test Cuvette, REF: ACT-LR, to be used with the Hemochron Signature ELITE Whole Blood Microcoagulation System
Test cuvettes, used with an assay for monitoring heparin anticoagulation, may have a foreign object that has sharp edges and could pose a risk of injury if not detected prior to handling.
Nov 19, 2025 Class III Accriva Diagnostics, Inc.
Device
VerifyNow PRUTest Platelet Reactivity Test REF 85225 UDI-DI code: 10711234150078 The VerifyNow PRUTest is a whole blood test used in the laboratory or point of care setting to measure the level of platelet P2Y12 rece…
Due to an device without a premarket clearance being incorrectly package and distributed.